Presently, there are over 20 screening platforms enabling therapy development efforts, By Roots Analysis

Advances in screening technologies have enabled the identification of interactive gene combinations, enabling the development of lead candidates that leverage the principle of synthetic lethality for cancer treatment


To order this 485+ page report, which features 195+ figures and 200+ tables, please visit To order this 485+ page report, which features 195+ figures and 200+ tables, please visit https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-/267.html


The USD 8 billion (by 2030) financial opportunity within the synthetic lethality-based drugs and targets market has been analyzed across the following segments:

§ Type of molecule

§ Small Molecule

§ Biologic


§ Target disease indication

§ Breast Cancer

§ Colorectal Cancer

§ Fallopian Tube Cancer

§ Gastric Cancer

§ Head and Neck Cancer

§ Lung Cancer

§ Ovarian Cancer

§ Peritoneal Cancer

§ Others


§ Type of synlet target

§ APE1 / Ref-1

§ Chk1

§ GLS1

§ PARP

§ Pol θ

§ PP2A

§ Wee1


§ Route of administration

§ Oral

§ Intravenous


§ Key geographical regions

§ North America

§ Europe

§ Asia Pacific

Rest of the World



The https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html, report features the following companies, which we identified to be key players in this domain:

§ AbbVie

§ AstraZeneca

§ AtlasMedx

§ BeiGene

§ Chordia Therapeutics

§ Clovis Oncology

§ GlaxoSmithKline

§ IDEAYA Biosciences

§ Mission Therapeutics

§ Pfizer

§ Repare Therapeutics

§ Sierra Oncology

§ SyntheX Labs


Table of Contents


1. Preface


2. Executive Summary

3. Introduction to DNA Damage and Repair Systems


4. Introduction to Synthetic Lethality


5. Market Overview


6. Company Profiles


7. Emerging Trends on Social Media



8. Publication Analysis


9. Abstract Analysis


10. Academic Grants Analysis


11. Funding and Investment Analysis


12. Target Benchmark Analysis


13. Role of Companion Diagnostics in Synthetic Lethality


14. Market Forecast


15. Concluding Remarks


16. Executive Insights


17. Appendix 1: Tabulated Data


18. Appendix 2: List of Companies and Organizations



https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

Follow
4.7 Star App Store Review!
Cpl.dev***uke
The Communities are great you rarely see anyone get in to an argument :)
king***ing
Love Love LOVE
Download

Select Collections